Weight-loss drugs like Ozempic are in such huge demand that spending on them will hit $100 billion by 2035, analyst says

The buzz among investors has been on the rise after a study showed obesity drug Wegovy reduced the risks of heart attacks and strokes.

Posted from: this blog via Microsoft Power Automate.